重组组织型纤维蛋白酶原激活剂静脉溶栓治疗56例急性脑梗死临床观察

目的 探讨重组组织型纤维蛋白酶原激活剂(rt-PA)静脉溶栓治疗发病4.5 h内急性脑梗死的临床疗效及并发症.方法 选择发病4.5 h内的急性脑梗死患者56例,在常规治疗的基础上,应用rt-PA静脉溶栓治疗,剂量为0.9 mg/kg,最大剂量90 mg,将总剂量的10%团注,持续1min,将剩余的90%静脉滴注1 h.结果 治疗后24 h,美国国立卫生研究院卒中量表(NIHSS)评分中位数由7分降为4分(P=0.001);治疗后14d,NIHSS中位数为4分,较治疗前明显下降(P=0.002);治疗后21d,有效率为42.9%(24/56);治疗后90d,改良Rankin评分临床转归良好21例(37.5%).死亡8例,病死率为14.3%(8/56).经头颅CT证实出血转化7例,其中3例为症状性出血转化,2例为死亡原因,症状性出血转化率为5.4%(3/56).结论 rt-PA静脉溶栓治疗发病4.5 h内的急性脑梗死安全有效,并可以改善预后.     

急性重症脑梗死患者rt-PA静脉溶栓后出血转化发生状况及影响因素

目的探讨急性重症脑梗死患者重组人组织纤溶酶原激活剂(rt-PA)静脉溶栓后出血转化的发生状况及影响因素。方法回顾性分析102例急性重症脑梗死患者的临床资料,统计rt-PA静脉溶栓后出血转化发生情况,经单因素和多因素Logistic回归分析探讨rt-PA静脉溶栓后发生出血转化的影响因素。结果102例急性重症脑梗死患者rt-PA静脉溶栓后出血转化发生率为18.63%(19/102)。单因素分析和多因素Logistic回归分析显示,合并高血压、有酗酒史及治疗前NIHSS评分高是急性重症脑梗死患者rt-PA静脉溶栓后发生出血转化的危险因素(P<0.05)。结论合并高血压、有酗酒史以及治疗前NIHSS评分高是急性重症脑梗死患者rt-PA静脉溶栓后发生出血转化的危险因素,临床需采取针对性干预措施,以减少溶栓后出血转化的发生。     

多普勒超声对脑梗死rt-PA溶栓患者治疗效果的诊断价值分析

目的观察多普勒超声对脑梗死rt-PA溶栓患者治疗效果的诊断价值。方法选取2016年5月-2017年5月在我院接受治疗的80例脑梗死患者为研究对象,所有患者均接受rt-PA溶栓治疗。观察在不同治疗阶段脑梗死患者超声指标、NIHSS评分的差异,分析脑梗死rt-PA溶栓患者超声指标与NIHSS评分的相关性。结果溶栓前脑梗死患者的TIBI分级为2.86±0.34,溶栓后2 h、24 h、72 h和溶栓后7 d,脑梗死患者的TIBI分级分别为4.38±0.51、4.38±0.51、4.89±0.38、4.95±0.97,较溶栓前明显增高(P0.05);溶栓前,脑梗死患者的NIHSS评分为18.52±1.48分,溶栓后2 h、24 h、72 h和溶栓后7 d,脑梗死患者的TIBI分级分别为14.08±1.35分、11.21±1.37分、8.45±1.02分、5.13±0.98分,较溶栓前明显降低,差异有统计学意义(P0.05);采用Pearson相关分析法分析脑梗死rt-PA溶栓患者TIBI分级水平与NIHSS评分的相关性,结果显示,脑梗死rt-PA溶栓患者的TIBI分级水平与NIHSS评分呈负相关关系(r=-0.415,P0.001)。结论多普勒超声对脑梗死rt-PA溶栓患者治疗效果有较好的诊断价值,且超声指标与患者的NIHSS评分相关,随着超声TIBI分级的增加,患者的神经功能缺损程度明显改善,此项技术具有良好的临床应用价值。     

静脉溶栓治疗对轻型急性缺血性脑卒中患者颅内出血和远期预后的影响

目的探讨应用重组组织型纤溶酶原激活剂(rt-PA)静脉溶栓治疗轻型急性缺血脑卒中的安全性和远期有效性。方法选取2014年1月~2015年12月我院收治的轻型急性缺血性脑卒中患者160例,发病时间均﹤4.5h,根据治疗方式分为研究组56例和对照组104例,研究组应用静脉溶栓治疗,对照组应用抗血小板聚集或抗凝药物常规治疗,观察比较两组患者用药期间颅内出血情况和治疗后90d预后情况。结果研究组颅内出血3例(5.36%),症状性颅内出血1例(1.79%),对照组颅内出血2例(1.92%),症状性颅内出血1例(0.96%),两组颅内出血率和症状性颅内出血率比较,差异无统计学意义(P﹥0.05);研究组治疗90d后,预后良好36例(64.29%),对照组26例(25.00%),两组比较差异有统计学意义(P﹤0.05)。结论静脉溶栓治疗急性缺血性轻型脑卒中,具有可靠的用药安全性和远期预后,临床应用效果良好。     

性别对rt-PA静脉溶栓治疗急性缺血性脑卒中患者疗效的影响

目的探讨性别对rt-PA静脉溶栓治疗急性缺血性脑卒中患者疗效的影响。方法本研究采用回顾性病例对照研究。从2009年2月到2012年9月连续收集发病4.5 h内rt-PA静脉溶栓治疗的急性缺血性脑卒中患者作为研究对象。根据性别的不同将符合入选标准的病例分为2组:(1)女性组:该组由39例发病4.5 h内rt-PA静脉溶栓治疗的女性急性缺血性脑卒中患者组成;(2)男性组,该组由42例发病4.5 h内rt-PA静脉溶栓治疗的男性急性缺血性脑卒中患者组成。采用改良的Rankin量表评价神经功能恢复状况。结果 2组在90d内溶栓预后良好率(61.54%和52.38%,P=0.406)、颅内出血的发生率(7.69%和9.52%,P=0.769)、症状性颅内出血的发生率(5.13%和7.14%,P=0.707)及死亡率(5.13%和7.14%,P=0.707),差异无统计学意义。结论女性组与男性组相比,在静脉溶栓后90 d预后良好率及90 d内颅内出血、症状性颅内出血、死亡发生率差异无统计学意义(P>0.05),性别对急性缺血性脑卒中患者静脉溶栓疗效无影响。     

急性脑梗死静脉溶栓治疗的临床分析

目的:通过对急性脑梗死静脉溶栓病例分析,探究阿替普酶(rt-PA)静脉溶栓的有效率及其影响因素.方法:回顾性分析发病6小时内使用rt-PA静脉溶栓的急性脑梗死患者26例,分析其疗效的影响因素.结果:26例溶栓病例的总有效率达65.38%;2h内、2~4.5h及4.5~6h内溶栓有效率分别为100%、53.3%及66.6%.溶栓前NIHSS评分4~10分者有效率为100%,11~20分者有效率为50%,20分以上者均无效(0%);超过80岁溶栓有效率为60%;总的脑出血并发症发生率为11.53%.结论:急性脑梗死患者,溶栓时间窗越早,溶栓前NIHSS评分越低,预后越好;高龄不是静脉溶栓绝对禁忌症;溶栓后脑出血发生率较低.     

不同溶栓治疗急性缺血性脑卒中患者临床疗效与安全性分析

目的比较静脉溶栓、动脉溶栓与动静脉联合溶栓治疗急性缺血性脑卒中的临床疗效及安全性比较。方法选择2012年12月至2015年12月急性缺血性脑卒中患者120例,以数字表法随机分为静脉溶栓组、动脉溶栓组与动静脉联合溶栓组(联合组)各40例。静脉溶栓组采用rt-PA(0.9mg/kg),1min内给予负荷量10%,而后60min静脉泵入,动脉溶栓组置入微导管至病变血管后,给予rt-PA(0.3mg/kg)60min内持续泵入。联合组入院后给予rt-PA(0.6mg/kg),1min内给予负荷量10%,而后30min静脉泵入,同时,行超选择性动脉溶栓rt-PA(0.3mg/kg)60min内持续泵入治疗。以美国国立卫生研究院卒中量表(NIHSS)评分比较3组患者治疗前后神经功能缺损程度,比较3组患者2周后临床症状改善程度。对于2组患者溶栓后出血转化进行评价,以颅脑CT/MRI检查结果,参照ECASS评分比较出血转化(HT)发生率,比较2组患者症状性脑出血发生率差异。结果治疗前,3组患者性别、年龄、血压水平及神经功能缺损程度评分(NIHSS)差异无统计学意义(P0.05)。治疗后,静脉组、动脉组与联合组临床总有效率[(16/40,40.00%)比(24/40,60.00%)比(29/40,72.55%),χ~2=2.698]逐渐增加,3组比较差异有统计学意义(P0.05)。静脉组、动脉组与联合组出血转化发生率HT型[(6/40,15.00%)比(2/40,5.00%)比(3/40,7.50%),χ~2=2.904],PH型[(4/40,10.00%)比(2/40,5.00%)比(2/40,5.00%),χ~2=2.873],症状性脑出血发生率[(3/40,7.50%)比(1/40,2.50%)比(1/40,2.50%),χ~2=2.452],3组比较差异有统计学意义(P0.05)。结论与静脉溶栓比较,动脉溶栓治疗可以明显提高缺血性脑卒中患者临床有效率,降低症状性脑出血发病率。与动脉溶栓比较,动静脉联合溶栓临床疗效提高,但其症状性脑出血发病率未见上升,安全性较好。     

哪些脑梗死患者该溶栓

rt-PA(重组组织型纤溶酶原激活剂)能溶解血栓,目前被认为是急性脑梗死最有效的治疗药物。脑梗死患者如在发病后3小时内接受溶栓治疗,32%可恢复到正常或症状明显改善。症状性出血是溶栓后可能发生的副反应。美国临床试验表明,经过3小时标准静脉溶栓,症状性脑出血发生率是6%,即100位使用该药的患者约6位会出现早期症状性脑出血,其中3位病情会发生恶化(加重或死亡)。如果高于     

选择性动脉溶栓治疗急性脑梗死36例临床分析

[目的]探讨选择性动脉溶栓治疗急性脑梗死的有效性和安全性。[方法]将某院收治的超早期脑梗死患者36例作为研究组,采用选择性动脉溶栓治疗,从股动脉插管至血管闭塞部位,尿激酶1万U/min持续泵人,用量25～100万单位;并选取同期年龄、病情、发病时间相匹配的超早期急性脑梗死患者36例作为对照组,给予静脉溶栓治疗,尿激酶150万U加入生理盐水100ml,静脉滴注30min。记录两组患者溶栓治疗前、后神经缺损变化及两组患者预后情况。[结果]①治疗前两组患者NIHSS评分差异无统计学意义(P﹥0.05);治疗后研究组NIHSS评分显著低于对照组,两组间数据差异有统计学意义(P﹤0.05)。②治疗28d后研究组患者显效20例(55.6%),总有效率为77.8%(28/36);对照组患者显效11例(30.6%),总有效率为69.4%(25/36)(P﹤0.05)。[结论]超早期脑梗死患者选择性动脉溶栓治疗能恢复患者脑部血流灌注,阻断脑梗死的病理过程,疗效更为显著。     

重组组织型纤溶酶原激活剂联合丁苯酞治疗急性脑梗死的临床疗效及对血浆基质金属蛋白酶9的影响

目的 观察重组组织型纤溶酶原激活剂(rt-PA)联合丁苯酞治疗急性脑梗死的临床疗效及对基质金属蛋白酶9(MMP-9)的影响.方法 选取110例急性脑梗死患者,按随机数字表法分为溶栓组和溶栓加丁苯酞组,每组55例.并选取55例健康体检者作为对照组.溶栓组除基础治疗外给予rt-PA溶栓治疗,溶栓加丁苯酞组给予rt-PA溶栓治疗的同时口服丁苯酞治疗,疗程为14 d.观察比较溶栓组和溶栓加丁苯酞组治疗前后ESS评分、血浆MMP-9水平的变化及临床疗效.结果 溶栓组和溶栓加丁苯酞组治疗前ESS评分、血浆MMP-9水平比较差异无统计学意义(P＞0.05),两组治疗后ESS评分均较治疗前显著升高,治疗后14、21d溶栓加丁苯酞组的ESS评分显著高于溶栓组,且随着疗程的延长,其升高的程度显著优于溶栓组(P＜0.01).治疗后3个月溶栓加丁苯酞组总有效率为85.5％(47/55),显著高于溶栓组的69.1％(38/55)(P＜0.05).对照组血浆MMP-9水平为(12.94±9.23)ng/L,溶栓组和溶栓加丁苯酞组治疗前血浆MMP-9水平分别为(14.13±7.58)、(14.37±8.16)ng/L,治疗后3h分别为(21.64±10.13)、(23.05±11.26)ng/L,均较治疗前显著升高(P＜0.01),且均显著高于对照组(P＜0.01),但两组间比较差异无统计学意义(P＞0.05).溶栓加丁苯酞组颅内出血发生率为7.3％(4/55),病死率为5.5％(3/55),溶栓组分别为10.9％(6/55)、7.3％(4/55),两组比较差异均无统计学意义(P＞0.05).治疗后发生颅内出血患者血浆MMP-9水平升高程度显著大于未发生颅内出血患者(P＜0.05).结论 rt-PA联合丁苯酞治疗急性脑梗死在提高临床疗效的基础上并未增加溶栓后的出血风险,且无严重的不良反应发生,有较好的安全性.     

传统凝血试验与血栓弹力图检测诊断腹部创伤患者凝血功能障碍的比较研究

目的比较传统凝血试验(conventional coagulation test, CCT)和血栓弹力图分析仪(thromboelastography,TEG)在诊断腹部创伤患者凝血功能障碍的价值。 方法选择2017年1月至2018年1月东南大学医学院附属江阴市人民医院普通外科收治的38例以腹部创伤为主患者同时进行CCT与TEG监测,比较两种检测方法诊断凝血功能障碍的敏感性与特异性;并对发现创伤后早期(≤6 h)患者亚组进行比较分析。 结果腹部创伤患者凝血功能障碍CCT阳性率(8例,21.1%)明显低于TEG(阳性21,55.2%,P<0.05);创伤后早期凝血功能障碍CCT阳性率(3/13,23.1%)亦明显低于TEG(9/13,69.2%,P<0.05)。 结论TEG诊断创伤后凝血功能障碍的敏感性与特异性明显优于CCT方法,特别是对于创伤后早期凝血功能障碍的诊断TEG更具有优势。     

Eating Habits and Food Additive Intakes Are Associated with Emotional States Based on EEG and HRV in Healthy Korean Children and Adolescents

Purpose: Recent study suggests that psychological issues and eating habits are closely related. In this study, we aimed to find the association between eating habits and intakes of artificial sweeteners with emotional states of schoolchildren using quantitatively analyzing objective biosignals.

Methods: The study was conducted at the National Standard Reference Data Center for Korean EEG as a cross-sectional study. Three hundred eighteen healthy children who have not been diagnosed with neurologic or psychiatric disorders were evaluated (168 girls and 150 boys; mean age of 11.8 ± 3.6 years). Analysis indicators were a dietary intake checklist for children's nutrition-related behavior score (NBS), consisting of 19 items; food frequency questionnaires (FFQs), consisting of 76 items; the Child Depression Inventory (CDI); State–Trait Anxiety Inventory–State (STAI-S); State–Trait Anxiety Inventory–Trait (STAI-T); electroencephalograph (EEG); and heart rate variability (HRV).

Results: Higher scores on the CDI, STAI-S, and STAI-T indicate negative emotions, and these scores were significantly decreased from the first to the fourth quartiles. The HRV results showed that the standard deviation of all normal-to-normal (SDNN) intervals was significantly higher in the first quartile than in the fourth quartile (p < 0.05). The intakes of artificial sweeteners and processed foods such as hamburgers correlate with higher theta/beta ratios, and intakes of natural foods such as legumes and fruits correlate with lower theta/beta ratios (p < 0.05).

Conclusions and Implications: From this result we confirmed a link between overall nutritional behavior, food additive intakes, and emotion in apparently healthy children and adolescents.     

创伤患者早期血糖变化与创伤严重程度的相关性分析

目的:比较创伤后患者早期血糖值与损伤严重度评分(ISS)的关系,了解早期血糖的变化规律和创伤的严重程度的关系。方法:选创伤后2h内入住的100例创伤患者,入院即刻取静脉血进行血糖值测定,同时给每位患者进行创伤严重度评分(ISS)。根据血糖测定值分为A组(<6.1mmol/L),B组(6.1～11.1 mmol/L),C组(>11.1 mmol/L),统计各组间患者的损伤严重度评分(ISS)。结果:C组(>11.1 mmol/L)的ISS值及病死率比A组(<6.1mmol/L)及B组(6.1～11.1 mmol/L)明显增高(P<0.01)。结论:创伤患者早期血糖水平增高,血糖的高低与创伤的程度呈正相关关系(r=0.587,P<0.01)。     

足月小于胎龄儿75例神经行为发育分析

目的 探讨足月小于胎龄儿神经行为发育特点.方法 选择西安西电集团医院2014年3月至2015年10月收治的足月小于胎龄儿75例作为研究对象,对其进行新生儿神经行为测定(NB NA)评分、振幅整合脑电图监测,并将研究对象按出生体重百分位数分为3组:Ⅰ组为小于同胎龄儿正常出生体重第10百分位(28例);Ⅱ组为小于同胎龄儿正常出生体重第5百分位(25例);Ⅲ组为小于同胎龄儿正常出生体重第3百分位(22例),对各组神经行为发育相关指标进行比较分析.结果 ①NBNA评分:75例患儿NBNA评分总分均低于36分,最高35分,最低27分,且3组间存在显著性差异(F=3.45,P＜0.05);②振幅整合脑电图(aEEG)监测:3组上下边界平均电压水平、窄带宽度、振幅异常率、异常aEEG率、成熟睡眠-觉醒周期(SWC)率均存在显著性差异(F值分别为5.25、4.85、5.17,x2值分别为9.12、9.12、11.23,均P＜0.05),但均未记录到爆发抑制及重度异常者.结论 足月小于胎龄儿常存在神经行为发育不成熟,且体重百分位数越低者成熟度越差.     

改良早期预警评分对高海拔地区多发伤的伤情判断和死亡预测

目的探讨改良早期预警评分(modified early warning score,MEWS)对高海拔地区多发伤患者伤重度和死亡风险的预测价值。方法收集51例多发伤患者临床资料,评估入院时MEWS分值,在完善各项检查后依据损伤严重度评分(injury severity score,ISS)分为轻伤组(16分)和重伤组(≥16分),根据医疗结果分为生存组和死亡组,比较轻重伤患者和生存及死亡患者MEWS的差异。采用受试者工作特征曲线(receiver operating characteristic curve,ROC曲线)评价MEWS,判断多发伤患者伤情和预后的准确性。结果轻伤组与重伤组MEWS分值分别为(2.63±2.00)和(6.53±3.36),差异有统计学意义(P0.05);MEWS多发伤伤重度ROC曲线下面积(AUC)为(0.839±0.070,P0.05)。生存组与死亡组患者初始MEWS分值分别为(4.84±2.07)和(9.38±3.50),差异有统计学意义(P0.05);MEWS多发伤患者死亡风险预测AUC为(0.834±0.069,P0.05)。结论 MEWS有助于对多发伤患者伤重度及死亡风险作出准确判断,MEWS4可作为重度多发伤的判断标准,MEWS9提示多发伤患者具有死亡风险。     

Comparison of different assessments for evaluating malnutrition in Chinese patients with end-stage renal disease with maintenance hemodialysis

Nutritional status can be evaluated by the malnutrition-inflammation score (MIS), bioelectrical impedance analysis (BIA), and modified quantitative subjective global assessment (MQSGA). This study sought to determine the value of these methods for detecting malnutrition in patients with end-stage renal disease (ESRD) who were undergoing maintenance hemodialysis. A total of 84 patients with ESRD with maintenance hemodialysis were recruited for the evaluation of their nutritional states by MQSGA, MIS, and BIA. The potential correlation among these methods was analyzed, and there was a significant difference in the percentage of patients with malnutrition as determined by these methods. Although only 1 of 84 patients had a body fat percentage that was below normal, based on the BIA, all of the patients displayed malnutrition as analyzed by MIS, and 56 of 84 patients had malnutrition as determined by MQSGA. Importantly, the MQSGA scores were positively correlated with the MIS scores (r = 0.924, r² = 0.855, P < .05), whereas no close association was found in results obtained by MQSGA score and BIA (r = −0.169, r² = 0.029, P > .05) in this population. Our data indicate that MIS, not BIA, is a sensitive method for the evaluation of malnutrition in Chinese patients with ESRD with maintenance hemodialysis.     

Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study

We aimed to assess the predictive value of the modified Glasgow prognostic score (mGPS) in patients with non-small cell lung cancer (NSCLC) who underwent stereotactic body radiation therapy (SBRT). We retrospectively reviewed the records of 207 patients, with a median age of 79 years. The pretreatment mGPS was calculated and categorized as high (mGPS = 1–2) or low (mGPS = 0). The median follow-up duration was 40.7 months. The five-year overall survival (OS), progression-free survival (PFS) and time to progression (TTP) rates were 44.3%, 36% and 54.4%, respectively. Multivariate analysis revealed that mGPS was independently predictive of OS (hazard ratio [HR] 1.67; 95% confidence interval 1.14–2.44: P = 0.009), PFS (HR 1.58; 1.10–2.28: P = 0.014) and TTP (HR 1.66; 1.03–2.68: P = 0.039). Patients who had high mGPS showed significantly worse OS (33.3 vs 64.5 months, P = 0.003) and worse PFS (23.8 vs 39 months, P = 0.008) than those who had low mGPS. The data showed a trend that patients with high mGPS suffered earlier progression compared to those with low mGPS (54.3 vs 88.1 months, P = 0.149). We confirmed that mGPS is independently predictive of prognosis in NSCLC patients treated with SBRT.     

Evaluating the impact of eligibility for free care on the use of general practitioner (GP) services: a difference-in-difference matching approach

In Ireland, approximately 30% of the population ('medical card patients') are entitled to free general practitioner (GP) care while the remaining 70% ('private patients') must pay the full cost of each visit. Previous research has analysed the effect of this system on GP visiting patterns using regression methods, but to date, no attempt has been made to apply techniques from the treatment evaluation literature to this issue. Treatment evaluation techniques are commonly employed when observations are not randomly assigned to treatment and control groups; this is certainly the case here, as the primary criterion for medical card eligibility is an income below a specified income threshold (and individuals may also be granted medical cards for other reasons such as chronic ill-health). In this paper, previous Irish research, which has analysed the effect of medical card eligibility on GP visiting using regression methods, is extended to consider the use of difference-in-difference matching methods, which control for non-random selection into treatment and control groups, as well as differences in time-invariant unobserved characteristics between individuals in both groups. The results are largely consistent with earlier results using pooled cross-sectional and panel data, and confirm that medical card eligibility exerts a significant effect on GP visiting, even after controlling for observed and unobserved differences in characteristics between medical card and private patients.     

磐安县部分女性MPS症状评分及影响因素分析

目的探讨围绝经期综合征(MPS)女性更年期症状评分及危险因素。方法选择2011年1月至2013年12期间在金华市磐安县妇幼保健院妇产科就诊的78例MPS患者为研究对象,选择同期在我院健康体检的72例健康女性为对照组使用女性版围绝经期Greene量表评估更年期症状。对更年期症状相关危险因素进行单因素及多因素Logistic回归分析。结果两组学历、与子女关系、性格方面比较,差异有统计学意义(x^2值分别为5.838、6.086、5.788,均P<0.05),观察组Greene评分显著高于对照组(t=9.962,P<0.05)。78例MPS患者中,轻度围绝经期症状27例(34.62%),中度围绝经期症状48例(61.54%),重度围绝经期症状3例(3.85%)。观察组症候群1~3评分显著高于对照组(t值分别为3.168、4.913、2.963,均P<0.05),观察组症候群4评分显著低于对照组(t=2.082,P<0.05)。低文化程度症候群1~3评分显著高于高文化程度(t值分别为2.019、1.990、2.287,均P<0.05);性格内向的女性症候群1~3评分显著高于性格外向组(t值分别为3.000、1.022、1.077,均P<0.05),子女关系较差的组别症候群2~3评分显著高于与子女关系好组(t值分别为3.190、3.265,均P<0.05)。结论 :MPS女性更年期症状和与子女关系、学历、性格密切相关。文化程度、与子女关系、性格、症候群1、症候群2、症候群3为MPS更年期症状的主要影响因素。     

弥散加权成像联合临床炎性指标诊断早期强直性脊柱炎骶髂关节病变研究

目的:探讨弥散加权成像(DWI)联合临床炎性指标在早期强直性脊柱炎(AS)骶髂关节病变中的应用。方法:选取医院拟诊为AS的80例患者,根据检查结果将其分为AS组(51例)和非AS组(29例),分别行磁共振成像(MRI)检查,应用加拿大脊柱骨关节研究协会评分系统(SPARCC)和Bath强直性脊柱炎病情活动指数(BASDAI)评分,测量表观弥散系数(ADC)值,探讨其ADC值与SPARCC评分、BASDAI评分的相关性,判断C反应蛋白(CRP)、红细胞沉降率(ESR)、BASDAI和SPARCC评分对AS骶髂关节病变的诊断价值,绘制受试者工作特征(ROC)曲线。结果:AS组患者ESR、CRP水平、ADC值、SPARCC和BASDAI评分均明显高于非AS组患者,差异有统计学意义(t=6.231,t=5.723,t=4.701,t=4.842,t=14.513;P<0.05)。Pearson相关性分析中,AS组患者ADC值与SPRCC评分、ESR、CR及BASDAI评分均呈正相关(r=0.524,r=0.434,r=0.693,r=0.542;P=0.000)。ADC值、SPARCC评分、BASDAI评分、CRP和ESR诊断AS的灵敏度分别为74.5%、76.5%、78.4%、72.6%和70.6%;特异度分别为65.5%、58.6%、62.1%、68.9%和72.4%;ROC曲线下面积(AUC)为0.713、0.700、0.725、0.712和0.710,联合诊断AS的灵感度和特异度分别为84.3%和55.2%,AUC为0.738。结论:DWI联合临床炎性指标、SPRCC评分和BASDAI评分的联合诊断具有较高的临床价值。